Nektar Therapeutics Archives

Nektar, BioMarin, and Alnylam top list of biotech M&A targets

https://pharmaphorum.com/news/nektar-biomarin-and-alnylam-top-list-of-biotech-ma-targets/

BMS makes record $1.8bn bet on Nektar cancer drug

https://pharmaphorum.com/news/bms-makes-record-1-8bn-bet-on-nektar-cancer-drug/

BMS and Nektar to pair Opdivo with natural killer cell drug

https://pharmaphorum.com/news/bms-nektar-pair-opdivo-natural-killer-cell-drug/

Search